Please provide your email address to receive an email when new articles are posted on . The study treatment, PT027, is a potential first-in class inhaled, fixed-dose combination rescue medication ...
Young woman using asthma inhaler at home. The NDA submission is supported by data from the phase 3 MANDALA trial, which included 3132 patients with moderate to severe asthma. The Food and Drug ...
Risk Statement: There is a reasonable probability that failure to deliver the recommended dose to treat the respiratory symptoms of acute asthma exacerbations such as wheezing coughing, shortness of ...
As asthma symptoms worsen, patients typically rely on short-acting β 2-agonist (SABA) rescue therapy, but SABAs do not address worsening inflammation, which leaves patients at risk for severe asthma ...
Credit: Getty Images. The recall affects products manufactured in November 2021. Cipla has initiated a recall of 6 batches of Albuterol Sulfate Inhalation Aerosol, 90mcg (200 metered inhalation) due ...
Albuterol is a common rescue medication that people with COPD can use as an inhaler or nebulizer. Side effects are usually mild, but rare and serious cardiac side effects can occur. Albuterol is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results